Analysis of the IgVH somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course

Blood

Volumn 99, Issue 4, 2002, Pages 1299-1304

  Algara, Patricia ^a,b,c,d   Mateo, Marisol S ^a,b,c,d   Sanchez Beato, Margarita ^a,b,c,d   Mollejo, Manuela ^a,b,c,d   Navas, Immaculada C ^a,b,c,d   Romero, Lourdes ^a,b,c,d   Solé, Francesc ^a,b,c,d   Salido, Marta ^a,b,c,d   Florensa, Lourdes ^a,b,c,d   Martínez, Pedro ^a,b,c,d   Campo, Elias ^a,b,c,d   Piris, Miguel A ^a,b,c,d,e  

^a HOSPITAL VIRGEN DE LA SALUD   (Spain)

^b Molecular Oncology Programme   (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PROTEIN IGVH; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; CANCER SURVIVAL; CELL POPULATION; CHROMOSOME 7Q; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; GENE DELETION; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; LYMPHOMA; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOMATIC MUTATION; SPLEEN; TUMOR GROWTH;

EID: 0037082501     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.4.1299     Document Type: Article

References (37)

1. Lymph node involvement by splenic marginal zone lymphoma morphological an immunohistochemical features
2. Splenic marginal zone lymphoma
3. The histopathology of splenic marginal lymphoma with villous lymphocytes
4. Intrasinusoidal bone marrow infiltration: A possible hallmark of splenic lymphoma
5. Splenic marginal zone lymphoma with increased number of blasts: An aggressive variant?
6. 7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma
7. Splenic marginal zone B-cell lymphomas: Two cytogenetic subtypes, one with gain of 3q and the other with loss of 7q
8. Molecular heterogeneity of splenic marginal zone lymphomas: Analysis of mutations in the 5′ noncoding region of the bcl-6 gene
9. A marginal zone pattern may be found in different varieties of non-Hodgkin's lymphoma: The morphology and immunohistology of splenic involvement by B-cell lymphomas simulating splenic marginal zone lymphoma
10. Clinical relevance of immunoglobulin mutation analysis
11. Mutations of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes
12. BCL-6 mutations in normal germinal centre B cells: Evidence of somatic hypermutation acting outside Ig loci
13. Maturation of the immune response in germinal centres
14. Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections
15. Analysis of somatic mutation in five B cell subsets of human tonsil
16. Evidence for a large compartment of IgM-expressing memory B cells in humans
17. Cellular origin of human B-cell lymphomas
18. Molecular insights into the immunopathogenesis of follicular lymphoma
19. Molecular analysis of immunoglobulin genes in diffuse large B-cell lymphomas
20. Myeloma Ig heavy chain V region sequences reveal prior anti-genic selection and marked somatic mutation but no intraclonal diversity
21. Analysis of VH genes used by neoplastic B cells in endemic Burkitt's lymphoma shows somatic hypermutation and intraclonal heterogeneity
22. Mantle cell (previously centrocytic) lymphomas express VH genes with no or very little somatic mutations like the physiologic cells of the follicle mantle
23. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors
24. H genes provides clinically valuable information in B-cell chronic lymphocytic leukemia
25. H genes are associated with a more aggressive form of chronic lymphocytic leukemia
26. IgV gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia
27. Splenic lymphoma with lymphocytes involves B cells with extensively mutated Ig heavy chain variable region genes
28. Analysis of immunoglobulin genes in splenic marginal zone lymphoma suggests ongoing mutation
29. Mutation analysis of the rearranged immunoglobulin heavy chain genes of marginal zone cell lymphomas indicates an origin from different marginal zone B lymphocyte subsets
30. Somatic mutation analysis of IgH variable regions reveals that tumor cells of most parafollicular (monocytoid) B-cell lymphoma, splenic marginal zone B-cell lymphoma, and some hairy cell leukaemia are composed of memory B lymphocytes
31. Splenic marginal zone lymphoma, a distinctive type of low-grade B-cell lymphoma: A clinicopathological study of 13 cases
32. The CDR1 sequences of a major proportion of human germline IgVH genes are inherently susceptible to amino acid replacement
33. Lack of allelic exclusion in B cell chronic lymphocytic leukemia
34. + B cells
35. Salivary gland mucosa-associated lymphoid tissue lymphoma immunoglobulin V(H) genes show frequent use of V1-69 with distinctive CDR3 features
36. V(H)1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen
37. The genetic variability of the VH genes in follicular lymphoma: The impact of the hypermutation mechanism